Dr. Jay is the Senior Managing Director of the Biomedical Value Fund, a $400 million hedge fund formed to invest in publicly-traded healthcare companies, and GPPI, a $155 million private equity fund investing in recapitalizations of rapidly growing health care service companies. Previously, he was General Partner and head of healthcare at Whitney & Co., an investment firm with over $5 billion under management. Prior to Whitney & Co., Dr. Jay was a Principal at Canaan Partners and an Associate at Salomon Brothers, Inc.
Dr. Jay earned his MD and BS from Boston University (magna cum laude and honors) and his MBA from Harvard Business School. Dr. Jay is on the Boards of the Boston University School of Medicine and the Westover School.